Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gel Tech Zicam Zinc Nasal Spray Is "Remedy For The Common Cold"

This article was originally published in The Tan Sheet

Executive Summary

Gel Tech's Zicam zinc gel nasal spray is a "fast-acting remedy for the common cold," product labeling says. Launched in January as a "homeopathic nasal gel," the product "helps reduce the duration of the common cold" and "helps relieve the symptoms of the common cold," packaging states.

You may also be interested in...



Zicam Originators Regroup To Develop OTC Cold Therapy

Anti Viral Technologies, Inc. hopes to have an innovative cold prevention therapy on the market by Fall 2006, the firm announced Aug. 31

Zicam Originators Regroup To Develop OTC Cold Therapy

Anti Viral Technologies, Inc. hopes to have an innovative cold prevention therapy on the market by Fall 2006, the firm announced Aug. 31

Zicam Originators Regroup To Develop OTC Cold Therapy

Anti Viral Technologies, Inc. hopes to have an innovative cold prevention therapy on the market by Fall 2006, the firm announced Aug. 31

Related Content

Topics

UsernamePublicRestriction

Register

PS089651

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel